27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Cara Therapeutics (NASDAQ:CARA) reported its Q1 earnings results on Monday, May 15, 2023 at 04:01 PM.
Here's what investors need to know about the announcement.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Earnings
Cara Therapeutics beat estimated earnings by 5.77%, reporting an EPS of $-0.49 versus an estimate of $-0.52.
Revenue was up $1.38 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.24 which was followed by a 33.23% drop in the share price the next day.
Here's a look at Cara Therapeutics's past performance:
Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
---|---|---|---|---|
EPS Estimate | -0.32 | -0.42 | -0.25 | -0.54 |
EPS Actual | -0.56 | -0.43 | -0.08 | -0.52 |
Revenue Estimate | 16.25M | 9.83M | 20.71M | 3.16M |
Revenue Actual | 3.26M | 10.81M | 23.00M | 4.79M |
To track all earnings releases for Cara Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.